Literature DB >> 19123960

Attenuation of diabetic complications by C-phycoerythrin in rats: antioxidant activity of C-phycoerythrin including copper-induced lipoprotein and serum oxidation.

Badrish Soni1, Nishant P Visavadiya, Datta Madamwar.   

Abstract

In the present study, the protective role of purified C-phycoerythrin (C-PE) against diabetic complications and Cu-mediated lipoprotein oxidation was evaluated. C-PE (25 and 50 mg/kg body weight per d) was administered to experimental streptozotocin-nicotinamide-induced type 2 diabetic male rats for 28 d. C-PE treatment successfully ameliorated diabetic complications by decreasing food intake, organ weights, serum concentrations of glucose, cholesterol, TAG, VLDL-cholesterol, creatinine, uric acid and thiobarbituric acid-reactive substances (TBARS), with increases in body weight, Hb, total protein, bilirubin and ferric-reducing ability of plasma values. Hepatic and renal tissues demonstrated significant decreases in TBARS, lipid hydroperoxide and conjugated diene contents, with increases in superoxide dismutase, catalase, glutathione peroxidase, reduced glutathione, vitamin E and vitamin C levels. Furthermore, the 4-week ex vivo and in vitro administration of C-PE (0.5 and 1.0 mg/ml) indicated a decrease in Cu-mediated serum oxidation. The kinetics of the LDL oxidation profile showed significant prolongation of the lag phase with declines in oxidation rate, conjugated dienes, lipid hydroperoxide and TBARS. Results indicated the involvement of C-PE in the amelioration of diabetic complications by significant reductions in oxidative stress and oxidised LDL-triggered atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19123960     DOI: 10.1017/S0007114508162973

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  7 in total

1.  Pharmaceutical Potential of a Novel Chitosan Derivative Schiff Base with Special Reference to Antibacterial, Anti-Biofilm, Antioxidant, Anti-Inflammatory, Hemocompatibility and Cytotoxic Activities.

Authors:  Sameh S Ali; El-Refaie Kenawy; Fatma I Sonbol; Jianzhong Sun; Marwa Al-Etewy; Asmaa Ali; Liu Huizi; Nessma A El-Zawawy
Journal:  Pharm Res       Date:  2018-11-07       Impact factor: 4.200

Review 2.  Exploring the structural aspects and therapeutic perspectives of cyanobacterial phycobiliproteins.

Authors:  Stuti N Patel; Ravi R Sonani; Diya Roy; Niraj Kumar Singh; Sanjukta Subudhi; Sunil Pabbi; Datta Madamwar
Journal:  3 Biotech       Date:  2022-08-13       Impact factor: 2.893

3.  Phycoerythrin extends life span and health span of Caenorhabditis elegans.

Authors:  Ravi Raghav Sonani; Niraj Kumar Singh; Anjali Awasthi; Birendra Prasad; Jitendra Kumar; Datta Madamwar
Journal:  Age (Dordr)       Date:  2014-10-11

Review 4.  Plastids of marine phytoplankton produce bioactive pigments and lipids.

Authors:  Parisa Heydarizadeh; Isabelle Poirier; Damien Loizeau; Lionel Ulmann; Virginie Mimouni; Benoît Schoefs; Martine Bertrand
Journal:  Mar Drugs       Date:  2013-09-09       Impact factor: 5.118

5.  C-phycoerythrin from Phormidium persicinum Prevents Acute Kidney Injury by Attenuating Oxidative and Endoplasmic Reticulum Stress.

Authors:  Vanessa Blas-Valdivia; Plácido Rojas-Franco; Jose Ivan Serrano-Contreras; Andrea Augusto Sfriso; Cristian Garcia-Hernandez; Margarita Franco-Colín; Edgar Cano-Europa
Journal:  Mar Drugs       Date:  2021-10-20       Impact factor: 5.118

Review 6.  Phycobiliproteins-A Family of Algae-Derived Biliproteins: Productions, Characterization and Pharmaceutical Potentials.

Authors:  Huaxin Chen; Hongtao Qi; Peng Xiong
Journal:  Mar Drugs       Date:  2022-07-09       Impact factor: 6.085

7.  Apoptotic potential of C-phycoerythrin from Phormidium sp. A27DM and Halomicronema sp. A32DM on human lung carcinoma cells.

Authors:  Datta Madamwar; Dipak K Patel; Swati N Desai; Kapil K Upadhyay; Ranjitsinh V Devkar
Journal:  EXCLI J       Date:  2015-04-10       Impact factor: 4.068

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.